Twist Bioscience Corporation
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $580.8M | $465.8M |
| FY2022 | — | $789.4M | $378.7M |
| FY2023 | — | $623.4M | $286.5M |
| FY2024 | — | $472.7M | $226.3M |
| FY2025 | — | $473.0M | $183.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $580.8M | $465.8M |
| FY2022 | — | $789.4M | $378.7M |
| FY2023 | — | $623.4M | $286.5M |
| FY2024 | — | $472.7M | $226.3M |
| FY2025 | — | $473.0M | $183.0M |